FXYD1 and central nervous system cancer: The differential expression analysis results showed that the mRNA expression levels of FXYD1, ZCCHC12, and PDE2A were highly expressed in normal brain tissues, while the other six genes were significantly upregulated in glioma samples (Supplementary Figure 3B).